Ilika PLC banner

Ilika PLC
LSE:IKA

Watchlist Manager
Ilika PLC Logo
Ilika PLC
LSE:IKA
Watchlist
Price: 27.35 GBX -0.55% Market Closed
Market Cap: £49.5m

Ilika PLC
Investor Relations

Ilika Plc is a pioneer in solid-state battery technology with their innovative Stereax micro batteries designed for Industrial IoT and MedTech markets, and their Goliath large format batteries for the electric vehicle and consumer electronics markets. The firm has two product lines, Stereax microbatteries and Goliath large-format batteries. Stereax batteries are designed for industrial Internet of things (IoT) and MedTech markets. Ilika works with its ecosystem of partners to provide them with customizable Stereax micro batteries that provide the specific power requirements to their IoT or MedTech applications. Stereax micro solid state batteries are also customizable in shape and form, stackable and operational at high temperatures. The firm's Goliath batteries are a large format Wh-level technology being developed for electric and plug-in hybrid electric vehicles and also consumer electronics. The firm has operations in the United States of America, China and Israel.

Show more
Loading
IKA
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jan 22, 2026
AI Summary
Q2 2026

Commercial Ramp: Ilika has begun generating initial revenues from its Stereax solid-state battery business, with the first purchase order for commercial-scale electrodes received and production underway via Cirtec Medical.

Product Milestones: The company has successfully shipped 10-amp-hour Goliath prototypes to automotive and non-automotive customers, marking a key step toward broader commercialization.

Licensing Model: Ilika continues to pursue an asset-light, IP-driven model with licensing and royalty agreements, already in place for Stereax and targeted for Goliath.

Financial Position: Half-year turnover was GBP 0.6 million, impacted by timing of grant income; cash balance at period-end was GBP 6.9 million, supplemented post-period by R&D tax credits.

Outlook: Management expects commercial revenue from Stereax product sales to increase in 2026, while Goliath licensing discussions are ongoing with multiple partners.

Customer Feedback: Customer evaluations are ongoing for both Stereax and Goliath deliveries, with results expected to help drive further adoption and commercial agreements.

Key Financials
Turnover
GBP 0.6 million
Cash Balance
GBP 6.9 million
Patents Granted
78
Other Earnings Calls
2026
2022

Management

Mr. Graeme Purdy
CEO & Executive Director
No Bio Available
Mr. Jason Robert Fredrick Stewart
Chief Financial Officer
No Bio Available
Mr. John Tinson
Vice President of Sales & Marketing
No Bio Available
Mr. Denis Pasero
Product Commercialisation Manager
No Bio Available

Contacts

Address
Romsey
Unit 10a The Quadrangle, Abbey Park Industrial Estate
Contacts
+442380111400.0
www.ilika.com